• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

公共医疗保险、候补者死亡率与活体供肝移植应用之间的潜在关联:对移植受者登记处的分析。

Potential association between public medical insurance, waitlist mortality, and utilization of living donor liver transplantation: An analysis of the Scientific Registry of Transplant Recipients.

机构信息

Division of Hepatobiliary and Abdominal Organ Transplant Surgery, University of Southern California, Los Angeles, California, USA.

Lawrence J. Ellison Institute for Transformative Medicine, University of Southern California, Los Angeles, California, USA.

出版信息

Clin Transplant. 2021 Oct;35(10):e14418. doi: 10.1111/ctr.14418. Epub 2021 Jul 19.

DOI:10.1111/ctr.14418
PMID:34236113
Abstract

BACKGROUND

The Affordable Care Act (ACA) and subsequent Medicaid expansion has increased utilization of public health insurance. Living donor liver transplantation (LDLT) increases access to transplant and is associated with improved survival but consistently represents < 5% of LT in the United States.

STUDY DESIGN

National registry data were analyzed to evaluate the impact of insurance payor on waitlist mortality and LDLT rates at LDLT centers since implementation of the ACA.

RESULTS

Public insurance [Medicare RR 1.18 (1.13-1.22) P < .001, Medicaid RR 1.22 (1.18-1.27) P < .001], Latino ethnicity (P < .001), and lower education level (P = .02) were associated with increased waitlist mortality at LDLT centers. LDLT recipients were more likely to have private insurance (70.4% vs. 59.4% DDLT, P < .001), be Caucasian (92.1% vs. 83% DDLT, P < .001), and have post-secondary education (66.8% vs. 54.1% DDLT, P < .001). Despite 78% of LDLT centers being located in states with Medicaid expansion, there was no change in LDLT utilization among recipients with Medicaid (P = .196) or Medicare (P = .273).

CONCLUSION

Despite Medicaid expansion, registry data suggests that patients with public medical insurance may experience higher waitlist mortality and underutilize LDLT at centers offering LDLT. It is possible that Medicaid expansion has not increased access to LDLT.

摘要

背景

平价医疗法案(ACA)和随后的医疗补助扩展增加了公共健康保险的利用率。活体供肝移植(LDLT)增加了接受移植的机会,与改善生存相关,但始终代表美国 LT 的<5%。

研究设计

国家登记数据进行分析,以评估自 ACA 实施以来,保险支付者对 LDLT 中心等待名单死亡率和 LDLT 率的影响。

结果

公共保险[医疗保险 RR 1.18(1.13-1.22)P<.001,医疗补助 RR 1.22(1.18-1.27)P<.001]、拉丁裔种族(P<.001)和较低的教育水平(P=.02)与 LDLT 中心等待名单死亡率增加相关。LDLT 受者更有可能拥有私人保险(70.4% vs. 59.4% DDLT,P<.001)、白种人(92.1% vs. 83% DDLT,P<.001)和接受过高等教育(66.8% vs. 54.1% DDLT,P<.001)。尽管 78%的 LDLT 中心位于实施医疗补助扩展的州,但 Medicaid 受者或 Medicare 受者的 LDLT 利用率没有变化(P=.196)或 Medicare(P=.273)。

结论

尽管 Medicaid 扩大了,但登记数据表明,拥有公共医疗保险的患者可能在提供 LDLT 的中心等待名单死亡率更高,并且 LDLT 的利用率较低。 Medicaid 扩展可能并未增加 LDLT 的机会。

相似文献

1
Potential association between public medical insurance, waitlist mortality, and utilization of living donor liver transplantation: An analysis of the Scientific Registry of Transplant Recipients.公共医疗保险、候补者死亡率与活体供肝移植应用之间的潜在关联:对移植受者登记处的分析。
Clin Transplant. 2021 Oct;35(10):e14418. doi: 10.1111/ctr.14418. Epub 2021 Jul 19.
2
Survival after LDLT in recipients ≥70 years old in the United States. An OPTN/UNOS liver transplant registry analysis.美国≥70 岁受者 LDLT 后的存活率。OPTN/UNOS 肝移植登记分析。
Clin Transplant. 2023 Nov;37(11):e15099. doi: 10.1111/ctr.15099. Epub 2023 Aug 17.
3
Impact of Race and Ethnicity on Outcomes for Children Waitlisted for Pediatric Liver Transplantation.种族和族裔对等待小儿肝移植的儿童预后的影响。
J Pediatr Gastroenterol Nutr. 2018 Mar;66(3):436-441. doi: 10.1097/MPG.0000000000001793.
4
Low utilization of adult-to-adult LDLT in Western countries despite excellent outcomes: International multicenter analysis of the US, the UK, and Canada.尽管成人对成人 LDLT 的效果非常好,但在西方国家的利用率仍然很低:来自美国、英国和加拿大的国际多中心分析。
J Hepatol. 2022 Dec;77(6):1607-1618. doi: 10.1016/j.jhep.2022.07.035. Epub 2022 Sep 25.
5
Affordable Care Act Medicaid expansion associated with increased liver transplant waitlist access without worsening mortality.平价医疗法案下的医疗补助扩张与增加肝移植候补名单准入相关,而不会导致死亡率恶化。
Liver Transpl. 2024 Jan 1;30(1):20-29. doi: 10.1097/LVT.0000000000000221. Epub 2023 Jul 25.
6
Association of the Affordable Care Act on Access to and Outcomes After Kidney or Liver Transplant: A Transplant Registry Study.平价医疗法案对肾或肝移植后获得和结果的影响:移植登记研究。
Transplant Proc. 2023 Jan-Feb;55(1):56-65. doi: 10.1016/j.transproceed.2022.12.008. Epub 2023 Jan 7.
7
Variation in adult living donor liver transplantation in the United States: Identifying opportunities for increased utilization.美国成人活体供肝移植的变化:发现增加利用率的机会。
Clin Transplant. 2023 Jul;37(7):e14924. doi: 10.1111/ctr.14924. Epub 2023 Feb 22.
8
Adult Living Donor Versus Deceased Donor Liver Transplant (LDLT Versus DDLT) at a Single Center: Time to Change Our Paradigm for Liver Transplant.单中心成人活体供肝与尸体供肝肝移植(LDLT 与 DDLT):是时候改变我们的肝移植模式了。
Ann Surg. 2019 Sep;270(3):444-451. doi: 10.1097/SLA.0000000000003463.
9
Use of living donor liver transplantation varies with the availability of deceased donor liver transplantation.使用活体供肝移植的情况因可供使用的尸体供肝移植而异。
Liver Transpl. 2012 Feb;18(2):160-5. doi: 10.1002/lt.22455.
10
Development, management, and resolution of biliary complications after living and deceased donor liver transplantation: a report from the adult-to-adult living donor liver transplantation cohort study consortium.发展、管理和解决活体和已故供体肝移植后的胆系并发症:来自成人对成人活体供肝移植队列研究联盟的报告。
Liver Transpl. 2013 Mar;19(3):259-67. doi: 10.1002/lt.23595.

引用本文的文献

1
The Affordable Care Act Improves Access, Survival, and Racial Disparities of Patients With Liver Disease: A Systematic Review.《平价医疗法案改善了肝病患者的就医机会、生存率及种族差异:一项系统评价》
Clin Gastroenterol Hepatol. 2025 Jul 7. doi: 10.1016/j.cgh.2025.04.032.
2
Living Donor Liver Transplantation with Small Left Lobe Grafts: Prospective Validation of Utility of Splenectomy in Selected Recipients.小左叶移植物活体肝移植:脾切除术在特定受者中效用的前瞻性验证
Ann Transplant. 2025 Jan 14;30:e946374. doi: 10.12659/AOT.946374.
3
Trends in candidate hepatitis C virus nucleic acid amplification test (NAT)+ listing and associated impacts on liver transplantation waitlist outcomes.
丙型肝炎病毒核酸扩增检测(NAT)阳性候选人名单的趋势及其对肝移植等待名单结果的相关影响。
Am J Transplant. 2025 Apr;25(4):793-803. doi: 10.1016/j.ajt.2024.10.016. Epub 2024 Oct 24.
4
Financial toxicity in living donor liver transplantation: A call to action for financial neutrality.活体肝移植中的财务毒性:呼吁财务中立。
Am J Transplant. 2024 Oct;24(10):1742-1754. doi: 10.1016/j.ajt.2024.05.012. Epub 2024 May 18.
5
Neighborhood-level Social Determinants of Health and Waitlist Mortality for Liver Transplantation: The Liver Outcomes and Equity Index.社区层面的健康社会决定因素与肝移植候补者死亡率:肝脏结局和公平指数。
Transplantation. 2024 Jul 1;108(7):1558-1569. doi: 10.1097/TP.0000000000004888. Epub 2024 Jun 20.
6
Can non-directed living liver donation help improve access to grafts and correct socioeconomic disparities in pediatric liver transplantation?非定向活体肝捐赠能否有助于改善供体获取途径并纠正小儿肝移植中的社会经济差异?
Pediatr Transplant. 2023 Mar;27(2):e14428. doi: 10.1111/petr.14428. Epub 2022 Nov 3.